Detalhe da pesquisa
1.
Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa.
BMC Public Health
; 23(1): 2291, 2023 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986070
2.
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
N Engl J Med
; 381(9): 803-815, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31339677
3.
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.
Open Forum Infect Dis
; 11(3): ofae007, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529213
4.
The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa.
Res Sq
; 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886557
5.
Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial.
AIDS
; 35(Suppl 2): S173-S182, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848584
6.
Weight gain stopping/switch rules for antiretroviral clinical trials.
AIDS
; 35(Suppl 2): S183-S188, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848585
7.
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
Lancet HIV
; 7(10): e666-e676, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010240
8.
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
AIDS
; 36(13): 1900-1901, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172876